65 Table 2. WST characteristics of patients with head and neck cancer and healthy subjects. Differences between test and retest outcome for patients with HNC and healthy subjects are depicted IQR: Interquartile range *: p<0.05, ‡: Wilcoxon Signed Ranks test 4 Healthy subjects (n = 40) p-value‡ 0.808 0.089 0.875 0.371 0.446 Retest Median (IQR) 3.00 (2.75) 4.11 (3.38) 33.33 (28.75) 24.33 (17.63) 1.34 (0.55) Mean (SD) 3.70 (2.11) 5.28 (4.01) 36.21 (22.09) 26.28 (13.24) 1.42 (0.43) Test Median (IQR) 3.00 (2.75) 3.90 (3.91) 33.33 (28.75) 25.71 (19.88) 1.35 (0.58) Mean (SD) 3.68 (2.02) 5.69 (5.19) 36.96 (24.09) 26.29 (14.03) 1.49 (0.62) Patients (n = 33) p-value‡ 0.069 0.080 0.046* 0.336 0.509 Retest Median (IQR) 4.00 (2.00) 6.00 (6.50) 25.00 (13.33) 16.67 (13.41) 1.75 (0.96) Mean (SD) 4.61 (2.68) 10.76 (12.18) 29.08 (17.66) 16.09 (9.41) 2.28 (1.89) Test Median (IQR) 4.00 (3.50) 7.00 (7.50) 25.00 (17.86) 14.29 (11.88) 1.75 (1.02) Mean (SD) 4.94 (2.69) 12.73 (17.57) 25.78 (12.14) 15.44 (10.53) 2.37 (2.35) Number of swallows Duration (s) Swallowing volume (mL) Swallowing capacity (mL/s) Swallowing speed (s)
RkJQdWJsaXNoZXIy MjY0ODMw